[Psychopharmacotherapy in pregnancy and lactation. 2: Lactation].
Whilst the incidence of psychiatric disorders decreases during pregnancy, the risk during the postpartum period increases significantly, often leading to the necessity of psychopharmacological intervention during the puerperium, and subsequently during lactation and breast-feeding. The necessity for lithium prophylaxis in manic-depressive women after childbirth has been identified, and it is recommended that weaning rather than omission of psychopharmacological treatment is preferable during the puerperium.
Lanczik
M
M
Department of Psychiatry, University of Birmingham, Queen Elizabeth Hospital, West Midlands, England.
Knoche
M
M
Fritze
J
J
D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D016651:Lithium Carbonate / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001523:Mental Disorders / Q000097:blood / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011644:Puerperal Disorders / Q000097:blood / Q000188:drug therapy*; D012307:Risk Factors
D011619:Psychotropic Drugs; D016651:Lithium Carbonate
Psychopharmakotherapie während Gravidität und Laktation. Teil 2: Laktation.